CRISPR Guide RNA for SAMD9 Allele Discrimination

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods fail to effectively distinguish and target dominant-mutated alleles causing genetic disorders like MIRAGE syndrome, leading to inadequate treatment options for such conditions.

Innovation Solution

A method utilizing CRISPR nuclease and a guide RNA molecule to introduce a double-strand break in the mutant allele of the SAMD9 gene, specifically targeting SNP positions to differentiate between functional and mutated alleles, thereby knocking out the expression of the mutated protein.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If current methods are used to target genetic alleles, then treatment coverage is limited, but the ability to distinguish and target dominant-mutated alleles specifically is insufficient

Engineering Contradiction:
Improveallele discrimination precisionVSAvoidtreatment coverage
Core Design Contradiction:
Measurement precisionVSAdaptability or versatility

Solution Approach 1:

The guide RNA is designed to recognize specific local nucleotide differences (SNPs) within the target allele, allowing precise discrimination between dominant-mutated and functional alleles by focusing on localized sequence variations rather than requiring comprehensive allele differentiation

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The CRISPR system segments the targeting function into modular components: the Cas9 nuclease provides the cutting mechanism while the customizable guide RNA provides allele-specific recognition, allowing the system to be adapted to different alleles by simply changing the guide sequence rather than redesigning the entire system

Inventive Principle:
Principle #1Segmentation

2Manufacturing precision

If CRISPR nuclease is used to create double-strand breaks, then allele inactivation precision is improved, but the complexity of the system increases

Engineering Contradiction:
Improveallele inactivation precisionVSAvoidsystem complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The guide RNA acts as an intermediary that bridges the Cas9 nuclease and the target allele, providing sequence-specific recognition without requiring the Cas9 protein itself to be allele-specific. This separates the recognition function from the cutting function, simplifying the overall system design while maintaining high precision

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The guide RNA sequence is designed to copy or match the specific nucleotide sequence of the target allele, allowing the system to recognize and target the correct allele through sequence complementarity rather than requiring complex structural recognition mechanisms

Inventive Principle:
Principle #26Copying

3Reliability

If dominant-mutated alleles are targeted for knockout, then disease treatment effectiveness is improved, but the risk of affecting functional alleles increases

Engineering Contradiction:
Improvedisease treatment effectivenessVSAvoidoff-target effects on functional alleles
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The guide RNA targets specific local nucleotide differences (SNPs) that are unique to the dominant-mutated allele, creating a highly specific recognition pattern that minimizes the risk of off-target effects on functional alleles while maintaining effective disease treatment

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The system exploits the asymmetric nucleotide differences between the dominant-mutated allele and the functional allele at specific SNP positions, designing guide RNAs that are asymmetric in their recognition requirements to ensure they only bind to the mutated allele and not the functional allele

Inventive Principle:
Principle #4Asymmetry

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach allows for precise inactivation of the mutant SAMD9 allele, potentially treating MIRAGE syndrome by enabling the expression of functional protein, thereby ameliorating or preventing the disease phenotype.

Implementation Method 1

a complex of the CRISPR nuclease and the first RNA molecule affects a double strand break in the mutant allele of the SAMD9 gene

Methodology Applied
Scientific EffectCRISPR nuclease DNA cleavage:

Data Source

PatentUS20230332146A1Differential knockout of a heterozygous allele of SAMD9
Publication Date: 2023.10.19 EMENDOBIO INC
  • US20230332146A1 patent drawing
  • US20230332146A1 patent drawing
  • US20230332146A1 patent drawing

AI summary

RNA molecules comprising a guide sequence portion having 17-50 contiguous nucleotides containing nucleotides in the sequence set forth in any one of SEQ ID NOs: 1-20640 and compositions, methods, and uses thereof.